Gene · 5205
Papers1,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cognitive Resilience in Brain Health and Dementia Research. | J Alzheimers Dis | 2022 | 36093713 | PubTator, text mining | PubMed |
| Case Report: Three novel pathogenic ABCC2 mutations identified in two patients with Dubin-Johnson syndrome. | Front Genet | 2022 | 36092886 | PubTator, text mining | PubMed |
| Identification of the pyroptosis-related prognostic gene signature and characterization of tumor microenvironment infiltration in triple-negative breast cancer. | Front Genet | 2022 | 36092879 | PubTator, text mining | PubMed |
| Prognostic Value of Copy Number Alteration Burden in Early-Stage Breast Cancer and the Construction of an 11-Gene Copy Number Alteration Model. | Cancers (Basel) | 2022 | 36077687 | PubTator, text mining | PubMed |
| Wireless-Powered Electrical Bandage Contact Lens for Facilitating Corneal Wound Healing. | Adv Sci (Weinh) | 2022 | 36073832 | PubTator, text mining | PubMed |
| High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer. | Nat Commun | 2022 | 36071033 | PubTator, text mining | PubMed |
| Guidelines for the Management of Cholestatic Liver Diseases (2021). | J Clin Transl Hepatol | 2022 | 36062287 | PubTator, text mining | PubMed |
| Bioinformatics Prediction and in vivo Verification Identify SLC7A5 as Immune Infiltration Related Biomarker in Breast Cancer. | Cancer Manag Res | 2022 | 36060214 | PubTator, text mining | PubMed |
| Research progress on RNA-binding proteins in breast cancer. | Front Oncol | 2022 | 36059653 | PubTator, text mining | PubMed |
| Whole-exome sequencing expands the roles of novel mutations of organic anion transporting polypeptide, ATP-binding cassette transporter, and receptor genes in intrahepatic cholestasis of pregnancy. | Front Genet | 2022 | 36046230 | PubTator, text mining | PubMed |
| Intestinal phages interact with bacteria and are involved in human diseases. | Gut Microbes | 2022 | 36037202 | PubTator, text mining | PubMed |
| Poxviral ANKR/F-box Proteins: Substrate Adapters for Ubiquitylation and More. | Pathogens | 2022 | 36014996 | PubTator, text mining | PubMed |
| A Systems Biology Approach to Investigate Kinase Signal Transduction Networks That Are Involved in Triple Negative Breast Cancer Resistance to Cisplatin. | J Pers Med | 2022 | 36013226 | PubTator, text mining | PubMed |
| Long-Term Results of Pediatric Liver Transplantation for Progressive Familial Intrahepatic Cholestasis. | J Clin Med | 2022 | 36012923 | PubTator, text mining | PubMed |
| CXCL14 Attenuates Triple-Negative Breast Cancer Progression by Regulating Immune Profiles of the Tumor Microenvironment in a T Cell-Dependent Manner. | Int J Mol Sci | 2022 | 36012586 | PubTator, text mining | PubMed |
| Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders. | Bioengineering (Basel) | 2022 | 36004917 | PubTator, text mining | PubMed |
| PTPRO-related CD8+ T-cell signatures predict prognosis and immunotherapy response in patients with breast cancer. | Front Immunol | 2022 | 36003382 | PubTator, text mining | PubMed |
| Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B. | Nat Immunol | 2022 | 36002648 | PubTator, text mining | PubMed |
| A novel age-related gene expression signature associates with proliferation and disease progression in breast cancer. | Br J Cancer | 2022 | 35995935 | PubTator, text mining | PubMed |
| Triple-negative breast cancer influences a mixed M1/M2 macrophage phenotype associated with tumor aggressiveness. | PLoS One | 2022 | 35960749 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5205/papers?page=19